Marvel Biosciences receives Australian patent allowance for MB-204
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (AMEX: MBCOF) | Delayed: 0.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.08 | 52 Week High | $ | |||
| Open | $0.08 | 52 Week Low | $ | |||
| Day High | $0.08 | P/E | N/A | |||
| Day Low | $0.08 | EPS | $ | |||
| Volume | 20,000 | |||||
| Marvell Technology Group Ltd (NASDAQ: MRVL) | Delayed: 223.47 -21.29 (8.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $244.76 | 52 Week High | $13.61 | |||
| Open | $231.20 | 52 Week Low | $7.40 | |||
| Day High | $236.20 | P/E | 349.17 | |||
| Day Low | $220.21 | EPS | $0.64 | |||
| Volume | 24,926,732 | |||||
